MarketCap
Ocular Therapeutix OCUL
€ 6.43
0.07%
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2014 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
187 M |
Marktkapitalisierung |
$ 1.35 B |
EBITDA (LTM) |
$ -266 M |
P/E (LTM) |
-7.492958 |
P/S (LTM) |
38.348624 |
EPS (LTM) |
-1.42 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 25.62 | 1.34 % | $ 3.89 B | Nasdaq Global Select Market,SPB | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
Black Diamond Therapeutics
BDTX
|
$ 1.7 | 1.19 % | $ 96.7 M | Nasdaq Global Select Market,SPB | USA |
 |
Cidara Therapeutics
CDTX
|
- | - | $ 1.41 B | Nasdaq Global Market | USA |
 |
AVEO Pharmaceuticals
AVEO
|
- | - | $ 521 M | Nasdaq Capital Market | USA |
 |
Dynavax Technologies Corporation
DVAX
|
- | - | $ 2.02 B | Nasdaq Capital Market | USA |
 |
Iterum Therapeutics
ITRM
|
- | - | $ 591 K | Nasdaq Global Select Market |  Irlanda |
 |
Cyclerion Therapeutics
CYCN
|
$ 34.99 | 3.77 % | $ 147 M | Nasdaq Global Select Market | USA |
 |
Humanigen
HGEN
|
- | -81.12 % | $ 4.28 M | Nasdaq Global Select Market | USA |
 |
Sorrento Therapeutics
SRNE
|
- | -29.58 % | $ 126 M | Nasdaq Global Select Market | USA |
 |
Surface Oncology
SURF
|
- | - | $ 59.7 M | Nasdaq Global Select Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Jounce Therapeutics
JNCE
|
- | - | $ 98.4 M | Nasdaq Global Select Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Verona Pharma plc
VRNA
|
- | - | $ 69.7 B | Nasdaq Global Select Market |  Britain |
 |
Corner Growth Acquisition Corp.
COOL
|
- | -0.89 % | $ 114 M | Nasdaq Global Select Market | USA |
 |
Clovis Oncology
CLVS
|
- | -7.23 % | $ 13 M | Nasdaq Global Select Market | USA |
 |
AIM ImmunoTech
AIM
|
$ 0.16 | 0.83 % | $ 259 K | NYSE American | USA |
 |
Mersana Therapeutics
MRSN
|
- | - | $ 3.56 B | Nasdaq Global Select Market | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 30.97 | 2.52 % | $ 1.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Altimmune
ALT
|
$ 2.31 | 0.38 % | $ 204 M | Nasdaq Global Market | USA |
 |
Aldeyra Therapeutics
ALDX
|
$ 0.79 | 0.23 % | $ 47.4 M | Nasdaq Global Select Market | USA |
 |
Concert Pharmaceuticals
CNCE
|
- | - | $ 401 M | Nasdaq Global Market | USA |
 |
Evelo Biosciences
EVLO
|
- | -14.46 % | $ 27.9 M | Nasdaq Global Select Market | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
- | - | $ 384 M | Nasdaq Global Select Market | Britain |
 |
Morphic Holding
MORF
|
- | - | $ 2.42 B | Nasdaq Global Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Akebia Therapeutics
AKBA
|
$ 0.7 | 0.27 % | $ 180 M | Nasdaq Global Market | USA |
 |
Akari Therapeutics, Plc
AKTX
|
$ 7.24 | 2.53 % | $ 487 B | Nasdaq Capital Market | Britain |
 |
Genocea Biosciences
GNCA
|
- | -15.0 % | $ 3.04 M | Nasdaq Global Select Market | USA |
 |
Nkarta
NKTX
|
$ 2.03 | 1.35 % | $ 150 M | Nasdaq Global Select Market | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 224.47 | 0.29 % | $ 29.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 26.08 | 0.12 % | $ 1.22 B | Nasdaq Global Select Market | USA |
 |
Amryt Pharma plc
AMYT
|
- | - | $ 621 M | Nasdaq Global Select Market | Britain |
 |
G1 Therapeutics
GTHX
|
- | - | $ 370 M | Nasdaq Global Select Market,SPB | USA |
 |
Amarin Corporation plc
AMRN
|
$ 11.61 | 0.26 % | $ 4.82 B | Nasdaq Global Market | Irlanda |
 |
Amneal Pharmaceuticals
AMRX
|
$ 18.9 | 1.38 % | $ 5.92 B | NYSE | USA |
 |
NexImmune
NEXI
|
- | 70.13 % | $ 4.12 M | Nasdaq Global Market | USA |
 |
AnaptysBio
ANAB
|
$ 46.67 | 2.37 % | $ 1.35 B | Nasdaq Global Select Market,SPB | USA |
 |
Anika Therapeutics
ANIK
|
$ 20.25 | 0.29 % | $ 290 M | Nasdaq Global Select Market,SPB | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 4.63 | 21.05 % | $ 20 M | Nasdaq Capital Market | Israel |
 |
IGM Biosciences
IGMS
|
- | - | $ 76.9 M | Nasdaq Global Select Market,SPB | USA |
 |
IMV
IMV
|
- | - | $ 13.1 M | Nasdaq Global Select Market |  Canada |
 |
Kinnate Biopharma
KNTE
|
- | - | $ 123 M | Nasdaq Global Select Market | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
- | - | $ 231 M | Nasdaq Global Market | USA |
 |
Karuna Therapeutics
KRTX
|
- | - | $ 12.2 B | Nasdaq Global Market,SPB | USA |
 |
Chimerix
CMRX
|
- | - | $ 756 M | Nasdaq Global Select Market | USA |
 |
Kaleido Biosciences
KLDO
|
- | -3.69 % | $ 12.4 M | Nasdaq Global Select Market | USA |
 |
Oncolytics Biotech
ONCY
|
$ 0.54 | 9.84 % | $ 51.8 M | Nasdaq Global Select Market | Canada |